Skip to main content
Equibles
DNLI logo

DNLI · Denali Therapeutics Inc.

Track DNLI — free

Use DNLI with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about DNLI

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$24.40 -0.42 (-1.69%) At close · Aug 14
Market Cap
$3.90B
Shares
159.85M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

Model estimate

Expected Aug 14 short interest

as of Aug 14
17,589,159 +0.9% vs reported
The latest estimate appears in the chart below. Official release expected Aug 25. Methodology
Short Squeeze Score
71/100
Short interest 10.9% of shares — P91 Days to cover 12.1 — P92 Price vs VWAP +7.3% — P73 Short-volume trend -9.5% — P19 Short interest change +8.7% — P76 Worst FTD 0.00% of shares — P35

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-31). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

1M 3M 6M 1Y 5Y All
Dimensions
  • Add to chart

    • Short Interest History

    Settlement Date Current Position Previous Position Change Days to Cover
    2026-08-31 Scheduled
    FINRA publishes Sep 10
    		 — — — —
    2026-08-14 Scheduled
    FINRA publishes Aug 25
    		 — — — —
    2026-07-31 17,434,654 16,035,916 +1,398,738 12.12
    2026-07-15 16,035,916 15,949,089 +86,827 8.39
    2026-06-30 15,949,089 15,407,744 +541,345 6.95
    2026-06-15 15,407,744 14,990,471 +417,273 8.43
    2026-05-29 14,990,471 14,026,925 +963,546 8.02
    2026-05-15 14,026,925 14,813,936 -787,011 7.51
    2026-04-30 14,813,936 15,284,401 -470,465 9.95
    2026-04-15 15,284,401 15,421,152 -136,751 11.04
    2026-03-31 15,421,152 14,258,580 +1,162,572 6.67
    2026-03-13 14,258,580 14,319,419 -60,839 9.53
    2026-02-27 14,319,419 13,594,971 +724,448 9.03
    2026-02-13 13,594,971 13,558,718 +36,253 8.71
    2026-01-30 13,558,718 14,858,586 -1,299,868 7.02
    2026-01-15 14,858,586 14,560,677 +297,909 9.68
    2025-12-31 14,560,677 13,092,563 +1,468,114 12.46
    2025-12-15 13,092,563 12,977,218 +115,345 6.15
    2025-11-28 12,977,218 14,017,386 -1,040,168 10.05
    2025-11-14 14,017,386 13,110,288 +907,098 9.06
    2025-10-31 13,110,288 14,527,782 -1,417,494 8.85
    2025-10-15 14,527,782 14,150,041 +377,741 8.52
    2025-09-30 14,150,041 13,079,532 +1,070,509 5.69
    2025-09-15 13,079,532 13,746,176 -666,644 5.54
    2025-08-29 13,746,176 13,471,070 +275,106 8.49
    Showing 1–23 of 23 settlements
    Key facts CIK 1714899 CUSIP 24823R105 13F (30d) 277 filings 272 filers Visit website Investor relations

    Report a Problem

    Category
    Description
    Email (optional, for follow-up)